Request SampleGlobal Patient Derived Xenograft or PDX Models Market Research Report 2022 - Market Size, Current Insights and Development Trends
SKU ID : Maia-21809228 | Publishing Date : 06-Oct-2022 | No. of pages : 110
Patients - Derived xenografts (PDX) are models of cancer in which tumors from patients with the above tissues or cells are injected into one or immunodeficient humanized mice. The PDX model mimics human tumor biology, allowing natural cancer progression and providing the most transformative research models to assess efficacy.
The Patient Derived Xenograft or PDX Models market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Patient Derived Xenograft or PDX Models market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Patient Derived Xenograft or PDX Models market.
Major Players in the Patient Derived Xenograft or PDX Models market are:
Xenopat (Spain)
Pharmatest Services Ltd.
Urolead
Bioduro (Us)
Oncodesign
Epo Berlin-Buch Gmbh
Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
Charles River Laboratories International Inc.
The Jackson Laboratory
Champions Oncology Inc.
Horizon Discovery Group Plc (Sage Labs Inc.)
Xentech
Shanghai Lide Biotech Co. Ltd. (China)
Crown Bioscience Inc.
Hera Biolabs
On the basis of types, the Patient Derived Xenograft or PDX Models market is primarily split into:
Mice Models
Rat Models
On the basis of applications, the market covers:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
2021
The Patient Derived Xenograft or PDX Models market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Patient Derived Xenograft or PDX Models market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Patient Derived Xenograft or PDX Models market.
Major Players in the Patient Derived Xenograft or PDX Models market are:
Xenopat (Spain)
Pharmatest Services Ltd.
Urolead
Bioduro (Us)
Oncodesign
Epo Berlin-Buch Gmbh
Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
Charles River Laboratories International Inc.
The Jackson Laboratory
Champions Oncology Inc.
Horizon Discovery Group Plc (Sage Labs Inc.)
Xentech
Shanghai Lide Biotech Co. Ltd. (China)
Crown Bioscience Inc.
Hera Biolabs
On the basis of types, the Patient Derived Xenograft or PDX Models market is primarily split into:
Mice Models
Rat Models
On the basis of applications, the market covers:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
Major Region
s or countries covered in this report:United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years:
2017-2021Base Year:
2021Estimated Year:
2022Forecast Period:
2022-2029Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
24/7 Research Support
Phone: +1 424 253 0807 
